Human mitochondrial transcription factor A functions in both nuclei and mitochondria and regulates cancer cell growth

Biochemical and Biophysical Research Communications

Volumn 408, Issue 1, 2011, Pages 45-51

  Han, Bin ^a,b   Izumi, Hiroto ^a   Yasuniwa, Yoshihiro ^a   Akiyama, Masaki ^a   Yamaguchi, Takahiro ^a   Fujimoto, Naohiro ^a   Matsumoto, Tetsuro ^a   Wu, Bin ^b   Tanimoto, Akihide ^c   Sasaguri, Yasuyuki ^a   Kohno, Kimitoshi ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Cancer; Cell cycle; Mitochondria; MtTFA; Nuclear transcription factor

Indexed keywords

MITOCHONDRIAL TRANSCRIPTION FACTOR A; SURVIVIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MALE; MITOCHONDRION; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION;

CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; DNA-BINDING PROTEINS; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 79955473279     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.03.114     Document Type: Article

References (33)

1. Bonawitz N.D., Clayton D.A., Shadel G.S. Initiation and beyond: multiple functions of the human mitochondrial transcription machinery. Mol. Cell 2006, 24:813-825.
2. Larsson N.G., Wang J., Wilhelmsson H., Oldfors A., Rustin P., Lewandoski M., Barsh G.S., Clayton D.A. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat. Genet. 1998, 18:231-236.
3. Takamatsu C., Umeda S., Ohsato T., Ohno T., Abe Y., Fukuoh A., Shinagawa H., Hamasaki N., Kang D. Regulation of mitochondrial D-loops by transcription factor A and single-stranded DNA-binding protein. EMBO Rep. 2002, 3:451-456.
4. Samudio I., Fiegl M., Andreeff M. Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism. Cancer Res. 2009, 69:2163-2166.
5. Baffy G. Uncoupling protein-2 and cancer. Mitochondrion 2010, 10:243-252.
6. Mayevsky A. Mitochondrial function and energy metabolism in cancer cells: past overview and future perspectives. Mitochondrion 2009, 9:165-179.
7. Weinberg F., Hamanaka R., Wheaton W.W., Weinberg S., Joseph J., Lopez M., Kalyanaraman B., Mutlu G.M., Budinger G.R., Chandel N.S. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc. Natl. Acad. Sci. USA 2010, 107:8788-8793.
8. Wallace D.C., Fan W. The pathophysiology of mitochondrial disease as modeled in the mouse. Genes Dev. 2009, 23:1714-1736.
9. Krynetskaia N.F., Phadke M.S., Jadhav S.H., Krynetskiy E.Y. Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage. Mol. Cancer Ther. 2009, 8:864-872.
10. Krynetskaia N., Xie H., Vucetic S., Obradovic Z., Krynetskiy E. High mobility group protein B1 is an activator of apoptotic response to antimetabolite drugs. Mol. Pharmacol. 2008, 73:260-269.
11. Minelli A., Bellezza I., Conte C., Culig Z. Oxidative stress-related aging: a role for prostate cancer?. Biochim. Biophys. Acta 2009, 1795:83-91.
12. Kidani A., Izumi H., Yoshida Y., Kashiwagi E., Ohmori H., Tanaka T., Kuwano M., Kohno K. Thioredoxin2 enhances the damaged DNA binding activity of mtTFA through direct interaction. Int. J. Oncol. 2009, 35:1435-1440.
13. Toki N., Kagami S., Kurita T., Kawagoe T., Matsuura Y., Hachisuga T., Matsuyama A., Hashimoto H., Izumi H., Kohno K. Expression of mitochondrial transcription factor A in endometrial carcinomas: clinicopathologic correlations and prognostic significance. Virchows Arch. 2010, 456:387-393.
14. Yoshida Y., Hasegawa J., Nezu R., Kim Y.K., Hirota M., Kawano K., Izumi H., Kohno K. Clinical usefulness of mitochondrial transcription factor A expression as a predictive marker in colorectal cancer patients treated with FOLFOX. Cancer Sci. 2011, 102:578-582.
15. Yoshida Y., Izumi H., Torigoe T., Ishiguchi H., Itoh H., Kang D., Kohno K. P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA. Cancer Res. 2003, 63:3729-3734.
16. Shiota M., Izumi H., Miyamoto N., Onitsuka T., Kashiwagi E., Kidani A., Hirano G., Takahashi M., Ono M., Kuwano M., Naito S., Sasaguri Y., Kohno K. Ets regulates peroxiredoxin1 and 5 expressions through their interaction with the high-mobility group protein B1. Cancer Sci. 2008, 99:1950-1959.
17. Ise T., Nagatani G., Imamura T., Kato K., Takano H., Nomoto M., Izumi H., Ohmori H., Okamoto T., Ohga T., Uchiumi T., Kuwano M., Kohno K. Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen. Cancer Res. 1999, 59:342-346.
18. Tanabe M., Izumi H., Ise T., Higuchi S., Yamori T., Yasumoto K., Kohno K. Activating transcription factor 4 increases the cisplatin resistance of human cancer cell lines. Cancer Res. 2003, 63:8592-8595.
19. Igarashi T., Izumi H., Uchiumi T., Nishio K., Arao T., Tanabe M., Uramoto H., Sugio K., Yasumoto K., Sasaguri Y., Wang K.Y., Otsuji Y., Kohno K. Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines. Oncogene 2007, 26:4749-4760.
20. Hirano G., Izumi H., Kidani A., Yasuniwa Y., Han B., Kusaba H., Akashi K., Kuwano M., Kohno K. Enhanced expression of PCAF endows apoptosis resistance in cisplatin-resistant cells. Mol. Cancer Res. 2010, 8:864-872.
21. Shiota M., Izumi H., Onitsuka T., Miyamoto N., Kashiwagi E., Kidani A., Yokomizo A., Naito S., Kohno K. Twist promotes tumor cell growth through YB-1 expression. Cancer Res. 2008, 68:98-105.
22. Miyamoto N., Izumi H., Noguchi T., Nakajima Y., Ohmiya Y., Shiota M., Kidani A., Tawara A., Kohno K. Tip60 is regulated by circadian transcription factor clock and is involved in cisplatin resistance. J. Biol. Chem. 2008, 283:18218-18226.
23. Shiota M., Izumi H., Onitsuka T., Miyamoto N., Kashiwagi E., Kidani A., Hirano G., Takahashi M., Naito S., Kohno K. Twist and p53 reciprocally regulate target genes via direct interaction. Oncogene 2008, 27:5543-5553.
24. Ueda T., Yoshida M. HMGB proteins and transcriptional regulation. Biochim. Biophys. Acta 2010, 1799:114-118.
25. Ryan B.M., O'Donovan N., Duffy M.J. Survivin: a new target for anti-cancer therapy. Cancer Treat. Rev. 2009, 35:553-562.
26. Miao G.Y., Lu Q.M., Zhang X.L. Downregulation of survivin by RNAi inhibits growth of human gastric carcinoma cells. World J. Gastroenterol. 2007, 13:1170-1174.
27. Lee H.C., Wei Y.H. Mitochondrial DNA instability and metabolic shift in human cancers. Int. J. Mol. Sci. 2009, 10:674-701.
28. Gough D.J., Corlett A., Schlessinger K., Wegrzyn J., Larner A.C., Levy D.E. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 2009, 324:1713-1716.
29. Kravchenko J.E., Rogozin I.B., Koonin E.V., Chumakov P.M. Transcription of mammalian messenger RNAs by a nuclear RNA polymerase of mitochondrial origin. Nature 2005, 436:735-739.
30. Mita A.C., Mita M.M., Nawrocki S.T., Giles F.J. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin. Cancer Res. 2008, 14:5000-5005.
31. Yang D., Welm A., Bishop J.M. Cell division and cell survival in the absence of survivin. Proc. Natl. Acad. Sci. USA 2004, 101:15100-15105.
32. Jiang Y., Saavedra H.I., Holloway M.P., Leone G., Altura R.A. Aberrant regulation of survivin by the RB/E2F family of proteins. J. Biol. Chem. 2004, 279:40511-40520.
33. Jung-Hynes B., Ahmad N. Role of p53 in the anti-proliferative effects of Sirt1 inhibition in prostate cancer cells. Cell Cycle 2009, 8:1478-1483.